<!DOCTYPE article
PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.3 20210610//EN" "JATS-archivearticle1-3-mathml3.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="abstract"><?properties open_access?><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Eur Psychiatry</journal-id><journal-id journal-id-type="iso-abbrev">Eur Psychiatry</journal-id><journal-id journal-id-type="publisher-id">EPA</journal-id><journal-title-group><journal-title>European Psychiatry</journal-title></journal-title-group><issn pub-type="ppub">0924-9338</issn><issn pub-type="epub">1778-3585</issn><publisher><publisher-name>Cambridge University Press</publisher-name><publisher-loc>Cambridge, UK</publisher-loc></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmc">PMC11863037</article-id><article-id pub-id-type="doi">10.1192/j.eurpsy.2024.295</article-id><article-id pub-id-type="other">EPP0064</article-id><article-id pub-id-type="pii">S0924933824002955</article-id><article-categories><subj-group subj-group-type="heading"><subject>Abstract</subject></subj-group><subj-group subj-group-type="section"><subject>e-Poster Presentation</subject></subj-group></article-categories><title-group><article-title>Aberrant Salience, Psychotic-Like Experiences, and Anxiety: a Case-Control Study</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Merola</surname><given-names>G. P.</given-names></name><xref rid="aff0567" ref-type="aff">
<sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Patti</surname><given-names>A.</given-names></name><xref rid="aff0567" ref-type="aff">
<sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Benedetti</surname><given-names>D.</given-names></name><xref rid="aff0568" ref-type="aff">
<sup>2</sup></xref><xref rid="cor0156" ref-type="corresp">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Bozza</surname><given-names>B.</given-names></name><xref rid="aff0567" ref-type="aff">
<sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ballerini</surname><given-names>A.</given-names></name><xref rid="aff0567" ref-type="aff">
<sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ricca</surname><given-names>V.</given-names></name><xref rid="aff0567" ref-type="aff">
<sup>1</sup></xref></contrib></contrib-group><aff id="aff0567">
<sup>1</sup>Psychiatry</aff><aff id="aff0568">
<sup>2</sup><institution>University of Florence</institution>, <city>Florence</city>, <country>Italy</country></aff><author-notes><corresp id="cor0156"><label>*</label>Corresponding author.</corresp></author-notes><pub-date publication-format="electronic" date-type="collection" iso-8601-date="2024-04"><month>4</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>27</day><month>8</month><year>2024</year></pub-date><volume>67</volume><issue seq="270">Suppl 1</issue><issue-title content-type="special_issue">Abstracts of the 32nd European Congress of Psychiatry</issue-title><fpage>S126</fpage><lpage>S126</lpage><permissions><copyright-statement>&#x000a9; The Author(s) 2024</copyright-statement><copyright-year>2024</copyright-year><copyright-holder>The Author(s)</copyright-holder><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbylicense">https://creativecommons.org/licenses/by/4.0/</ali:license_ref><license-p>This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (<uri xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</uri>), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.</license-p></license></permissions><self-uri xlink:title="pdf" xlink:href="S0924933824002955a.pdf"/><abstract><sec id="sec0936"><title>Introduction</title><p>In this research, we investigate how Aberrant Salience (AS), Psychotic-Like Experiences (PLEs), and anxiety are interlinked in both healthy individuals and subjects with psychotic disorders. AS is a trait contributing to a susceptibility to psychosis and anxiety, while PLEs are subclinical states often leading to psychosis. We hypothesize that AS impacts the occurrence and severity of PLEs, which in turn influences anxiety.</p></sec><sec id="sec0937"><title>Objectives</title><p>The goal is to offer a more nuanced understanding of the risk factors leading to psychotic disorders and to shed light on anxiety psychopathogenesis in healthy and psychotic populations.</p></sec><sec id="sec0938"><title>Methods</title><p>We used self-reported questionnaires like the Aberrant Salience Inventory (ASI), Community Assessment of Psychic Experiences (CAPE), and Symptom Check List-90-revised (SCL-90-R). Data analysis included descriptive statistics and mediation analysis, adjusting for age, gender, and education. Controls were sourced through convenience and snowball sampling, while out-patients diagnosed with Schizophrenia Spectrum Disorder, Bipolar Disorder with psychotic features, or Major Depression with psychotic features were recruited from Florence University Hospital.</p></sec><sec id="sec0939"><title>Results</title><p>A total of 207 participants were included, with 163 controls and 44 patients. Descriptive statistics are shown in <bold>Table 1.</bold> Mediation analysis showed that PLEs frequency acted as a mediator between AS and anxiety only in the control group (<bold>Figure 1</bold>), not in patients (<bold>Figure 2</bold>).<table-wrap position="anchor" id="tab2"><label>Table 1.</label><caption><p>Descriptive statistics - Mean &#x000b1; Std. Deviation.</p></caption><alternatives><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/><col align="left" width="1*" span="1"/></colgroup><thead><tr><th rowspan="1" colspan="1"/><th align="center" valign="middle" rowspan="1" colspan="1">Control Group (N=163)</th><th align="center" valign="middle" rowspan="1" colspan="1">Psychotic Group (N=44)</th><th align="center" valign="middle" rowspan="1" colspan="1">p-value
</th></tr></thead><tbody><tr><td align="left" valign="middle" rowspan="1" colspan="1">ASI</td><td align="center" valign="middle" rowspan="1" colspan="1">11.690 &#x000b1; 6.098</td><td align="center" valign="middle" rowspan="1" colspan="1">14.360 &#x000b1; 7.163</td><td align="right" valign="middle" rowspan="1" colspan="1"><bold>0.014</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CAPEposF</td><td align="center" valign="middle" rowspan="1" colspan="1">1.391 &#x000b1; 0.340</td><td align="center" valign="middle" rowspan="1" colspan="1">1.617 &#x000b1; 0.488</td><td align="right" valign="middle" rowspan="1" colspan="1"><bold>0.001</bold>
</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">CAPEposD</td><td align="center" valign="middle" rowspan="1" colspan="1">1.792 &#x000b1; 0.615</td><td align="center" valign="middle" rowspan="1" colspan="1">1.941 &#x000b1; 0.694</td><td align="right" valign="middle" rowspan="1" colspan="1">0.167</td></tr><tr><td align="left" valign="middle" rowspan="1" colspan="1">SCL-90-R-ANX</td><td align="center" valign="middle" rowspan="1" colspan="1">0.678 &#x000b1; 0.600</td><td align="center" valign="middle" rowspan="1" colspan="1">0.905 &#x000b1; 0.643</td><td align="right" valign="middle" rowspan="1" colspan="1"><bold>0.030</bold>
</td></tr></tbody></table><graphic xlink:href="S0924933824002955-FIG0012" position="anchor"/></alternatives><table-wrap-foot><p><bold>Legend:</bold> ASI, Aberrant Salience Inventory; CAPEposF, Community Assessment of Psychic Experiences - positive dimension - Frequency; CAPEposD, Community Assessment of Psychic Experiences - positive dimension - Distress; SCL-90-R-ANX, Symptom Check List-90-revised, Anxiety.</p></table-wrap-foot></table-wrap></p><p>
<bold>Image:</bold>
</p><p><fig position="float" id="fig0012"><graphic xlink:href="S0924933824002955-FIG0013" position="anchor"/></fig>
</p><p>
<bold>Image 2:</bold>
</p><p><fig position="float" id="fig0013"><graphic xlink:href="S0924933824002955-TABU0002" position="anchor"/></fig>
</p></sec><sec id="sec0940"><title>Conclusions</title><p>PLEs triggered by AS led to anxiety in the control group but not in psychotic patients. The discrepancy could be due to reduced novelty and awareness of experiences in the patient group. This may affect how bodily responses to PLEs are perceived and suggests the need for specialized treatment approaches for anxiety in these two groups.</p></sec><sec id="sec0941"><title>Disclosure of Interest</title><p>None Declared</p></sec></abstract><counts><page-count count="1"/></counts></article-meta></front></article>